dacarbazine and Conjunctivitis
dacarbazine has been researched along with Conjunctivitis in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Amaravadi, RK; Caro, I; Choe, CH; Kempen, JH; McArthur, GA | 1 |
Trials
1 trial(s) available for dacarbazine and Conjunctivitis
Article | Year |
---|---|
Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Conjunctivitis; Dacarbazine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Mutation; Neoplasm Staging; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Skin Neoplasms; Sulfonamides; Uveitis; Vemurafenib; Young Adult | 2014 |